AI-generated summary
The authors report a parallel controlled clinical trial of 36 patients with zygomaticomaxillary fractures and infraorbital nerve paresthesia who received 12 sessions of 810 nm laser photobiomodulation over six weeks, compared with 35 controls. Sensory tests showed some differences between groups at one and three months after therapy, and the authors conclude photobiomodulation may be an effective option for post-traumatic neurosensory disturbance.
- Who or what was studied
- Adults with zygomaticomaxillary complex fractures and sustained infraorbital nerve paresthesia (36 patients) and control cases (35)
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The abstract reports a small, single-center design with significant differences only at some time points and some tests, and it does not describe blinding or randomization.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Energy density (fluence)
- 27 J/cm2
- Power
- 200 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Visual analogue scale, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.